| What to watch today: Dow headed for steady open after Capitol Hill finally delivers on stimulus | | |  | TUE, DEC 22, 2020 | | | | AS OF TUE, DEC 22, 2020 • 08:35 ET | | Dow Jones Fut | | 30,216.45 | | Current: | 30,101.00 | | Change: | -12.00 | | Impl. Open: | -13.45 | | | S&P 500 Fut | | 3,694.92 | | Current: | 3,692.25 | | Change: | 6.50 | | Impl. Open: | 6.33 | | | NASDAQ 100 Fut | | 12,690.26 | | Current: | 12,743.25 | | Change: | 59.75 | | Impl. Open: | 55.99 | | | Russell 2000 Mini | | 1,970.33 | | Current: | 1,973.30 | | Change: | 7.20 | | Impl. Open: | 11.17 | | Apple (AAPL), a Dow-30 stock, was higher Monday and added about 3% to those gains in Tuesday's premarket on reports that the company is targeting 2024 to produce a passenger vehicle that could include its own breakthrough battery technology. The news sent Tesla (TSLA) shares falling to session lows on Monday. (Reuters)
* Lidar stocks soar after report that Apple is working on a car (CNBC) | | | | Both chambers of Congress also passed a seven-day stopgap spending bill to keep the federal government open during the time it takes Trump to sign the stimulus and funding package. The pandemic aid, which had been stalled for months and months, includes a $300-per-week federal unemployment supplement through mid-March and $600 in direct payments to most Americans. (CNBC) | | | The U.S. is looking into why a handful of people have suffered severe allergic reactions shortly after receiving the Pfizer-BioNTech Covid vaccines, a National Institute of Allergy and Infectious Diseases official told CNBC on Monday. The study, in the early planning phases, is expected to include several hundred people who have a history of severe allergic reactions.
The study comes as the government began distributing Pfizer's vaccine last week and Moderna's this week. Both vaccines, approved by the FDA for emergency use, employ a new approach to inoculations using genetic material to provoke an immune response. Dr. Anthony Fauci gets his first shot of Moderna's vaccine Tuesday, a day after President-elect Joe Biden got the Pfizer shot. (USA Today) | | | | As nations start Covid vaccinations, total deaths globally from the virus topped 1.7 million on more than 77.4 million cases. In the U.S., which has had the most infections, cumulative cases exceeded 18 million as fatalities approached 320,000. As of Monday, the seven-day average of daily new U.S. deaths was 2,655 and there were a record 115,351 people hospitalized with Covid. (CNBC) | | | | Undercutting Trump on multiple fronts, Attorney General William Barr said Monday he saw no reason to appoint a special counsel to look into the president's claims about the 2020 election or to name one for the tax investigation of President-elect Joe Biden's son. Barr, in his final public appearance as a member of Trump's Cabinet, also reinforced the belief of federal officials that Russia was behind a massive hack of U.S. government agencies, not China as the president has suggested. (AP) | | | | Goldman Sachs (GS), once reserved for the rich, is close to offering wealth management for the masses. The bank has begun internal testing of a new automated investment service ahead of a broader rollout early next year, according to an email obtained exclusively by CNBC. | | Sportsman's Warehouse (SPWH): Sportsman's Warehouse agreed to be bought by Cabela's parent Great American Outdoors Group, which will pay $18 per share for the sporting goods retailer. Sportsman's Warehouse had closed Monday at $12.65 per share. Sportsman's Warehouse shares soared 37% in the premarket. | | | | FuboTV (FUBO): The streaming TV service's stock surged more than 13% in premarket trading after Needham raised its price target to $60 per share. The stock jumped more than 26% Monday following an Axios report that it's considering forming exclusive partnership deals for live sports events. As of Monday's close, FuboTV was up 445% since its October IPO. | | | | Fitbit (FIT): Fitbit shares are under pressure, falling more than 5% in premarket trading after Australia's antitrust regulator rejected Google's proposals for addressing competition concerns surrounding its planned $2.1 billion takeover of the fitness device maker. | | | | CarMax (KMX): The auto retailer reported quarterly earnings of $1.42 per share, beating the consensus estimate of $1.14 a share. Revenue also came in above Wall Street forecasts, however comparable used-vehicle sales were down 0.8% compared to a FactSet consensus estimate of a 1% increase. Carmax shares fell 2% in premarket trading. | | | | SolarWinds (SWI): SolarWinds is indicated higher for a second straight day, after losing nearly 40% of its value last week. The network management company is at the center of the hack by a foreign government that compromised federal agencies and tech and accounting firms across the U.S., after hackers attached a malicious code to a software update. SolarWinds shares rose nearly 7% in premarket trading. | | | | Illumina (ILMN): The developer of gene sequencing technology was upgraded to "overweight" from "neutral" at Piper Sandler, based on expansion into cancer screening and Illumina's overall position as a leader in disease detection. The company's shares rose 1.3% in the premarket. | | |
Post a Comment